| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/07/2011 | US20110165261 Antimicrobial compositions and methods of use |
| 07/07/2011 | US20110165251 Liquid dosage compositions of stable nanoparticulate active agents |
| 07/07/2011 | US20110165230 Attenuated live vaccines |
| 07/07/2011 | US20110165226 Influenza cap-leader sequence |
| 07/07/2011 | US20110165224 Vaccines for inclusion body hepatitis |
| 07/07/2011 | US20110165220 Drugs to prevent hpv infection |
| 07/07/2011 | US20110165204 Gastric therapies and compositions therefor |
| 07/07/2011 | US20110165203 A topical composition comprising the isolated non-polar lipid fraction of lanolin4 |
| 07/07/2011 | US20110165202 Solid state forms of fosamprenavir calcium salt and processes for preparation thereof |
| 07/07/2011 | US20110165197 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 07/07/2011 | US20110165193 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165192 Methods for producing vaccine adjuvants |
| 07/07/2011 | US20110165191 Tat dna sequences, gene constructs, vaccine and processes thereof |
| 07/07/2011 | US20110165190 Compositions and Methods for Immunizing Against Immunodeficiency Viruses |
| 07/07/2011 | US20110165188 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/07/2011 | US20110165182 Conjugate of an antibody against ccr5 and an antifusogenic peptide |
| 07/07/2011 | US20110165172 Method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection |
| 07/07/2011 | US20110165163 Identification of a conserved inner core oligosaccharide of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 07/07/2011 | US20110165124 Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients |
| 07/07/2011 | US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof |
| 07/07/2011 | US20110165122 Method for targeted and sustained antiviral therapy |
| 07/07/2011 | US20110165121 Use of pegylated type iii interferons for the treatment of hepatitis c |
| 07/07/2011 | US20110165120 Inhibitors of serine proteases |
| 07/07/2011 | US20110165119 Telaprevir dosing regimen |
| 07/07/2011 | US20110165118 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 07/07/2011 | US20110165113 Polymer conjugates of v681-like peptides |
| 07/07/2011 | US20110165097 Compositions for percutaneous administration |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/07/2011 | US20110165093 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
| 07/07/2011 | US20110165091 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165090 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165064 Methods and compositions related to clot-binding compounds |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | US20110162982 Methods for producing vaccine adjuvants |
| 07/07/2011 | CA2786169A1 Materials and methods for prevention and treatment of viral infections |
| 07/07/2011 | CA2786090A1 Interferon analogs |
| 07/07/2011 | CA2785978A1 Cyclosporine analogues |
| 07/07/2011 | CA2785810A1 Pythium immunotherapy |
| 07/07/2011 | CA2785461A1 Compositions and methods for treating hepatitis b virus infection |
| 07/07/2011 | CA2783230A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| 07/07/2011 | CA2783216A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 07/07/2011 | CA2783213A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 07/06/2011 | EP2341078A2 Monoclonal antibody against rhesus D |
| 07/06/2011 | EP2341075A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341074A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341065A2 Inhibitors of serine proteases, particularly HCV NS3-NS4a protease |
| 07/06/2011 | EP2341063A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341062A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2341058A2 Oligonucleotide Analogues |
| 07/06/2011 | EP2341057A2 Oligonucleotide Analogues |
| 07/06/2011 | EP2341053A1 Cephalosporin having catechol group |
| 07/06/2011 | EP2341050A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2340846A1 Caspofungin formulations |
| 07/06/2011 | EP2340844A1 Anti-avian influenza virus agent, and product containing anti-avian influenza virus agent |
| 07/06/2011 | EP2340842A1 Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter |
| 07/06/2011 | EP2340836A1 Co-crystals comprising VX-950 and their pharmaceutical compositions |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340241A1 Organic compounds for applications in bacterial infections treatment |
| 07/06/2011 | EP2340045A1 Polymer conjugates of protegrin peptides |
| 07/06/2011 | EP2340022A1 Combination therapy for tuberculosis |
| 07/06/2011 | EP1740206B1 Phep, an amino acid permease of staphylococcus aureus |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | EP1146906B1 Mucosal delivery system |
| 07/06/2011 | CN1953982B 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 07/06/2011 | CN1925864B Plant-based medicament for the treatment of hepatitis c |
| 07/06/2011 | CN102119217A Novel lipid formulations for nucleic acid delivery |
| 07/06/2011 | CN102115755A Pichia expression PCV2 (porcine circovirus 2) ORF2 (open reading frame 2) protein and subunit vaccine |
| 07/06/2011 | CN102115729A Method for culturing baby hamster kidney (BHK) 21 cell in serum-free way, and vaccine preparation method |
| 07/06/2011 | CN102115494A Tick antibacterial peptide, gene thereof and application of same |
| 07/06/2011 | CN102115485A Prodrug based on cytosine arabinoside structure, and synthesis method and application thereof |
| 07/06/2011 | CN102115484A Amphotericin B degraded product, preparation method and application thereof |
| 07/06/2011 | CN102115467A Method for preparing catechin monomers |
| 07/06/2011 | CN102114243A Method for preparing polyvalent vaccine of primary hamster kidney cells of flu |
| 07/06/2011 | CN102114242A Tissue inactivation vaccine for bigfoot disease of giant salamander and preparation method thereof |
| 07/06/2011 | CN102114241A Attenuated live vaccine and application thereof |
| 07/06/2011 | CN102114238A Ointment for treating herpes zoster and preparation method thereof |
| 07/06/2011 | CN102114234A TCM oral decoction for treating common cold |
| 07/06/2011 | CN102114227A Pharmaceutical composition for treating hepatitis B and cirrhosis |
| 07/06/2011 | CN102114217A Traditional Chinese medicine fumigant for treating tinea capitis |
| 07/06/2011 | CN102114216A Externally applied antibacterial and antiphlogistic medicament and preparation method thereof |
| 07/06/2011 | CN102114211A Chinese herbal medicine for treating hepatopathy |
| 07/06/2011 | CN102114201A Chinese medicinal composition for treating infectious bursal disease and preparation method thereof |
| 07/06/2011 | CN102114197A Traditional Chinese medicine oral decoction for treating influenza |
| 07/06/2011 | CN102114196A Chinese herbal tea for treating acute viral myocarditis |
| 07/06/2011 | CN102114180A Chinese medicinal oral decoction for treating chronic pharyngitis |
| 07/06/2011 | CN102114171A Traditional Chinese medicine composition for treating cow endometritis |
| 07/06/2011 | CN102114166A Chinese medicinal ointment and manufacturing method thereof |
| 07/06/2011 | CN102114155A Serial Chinese medicinal preparation for treating phaseolus cold and preparation process and quality control method thereof |
| 07/06/2011 | CN102114151A Traditional Chinese medicine prescription for treating dermatophytosis |
| 07/06/2011 | CN102114134A Traditional Chinese medicine composition for treating disease of livestock and fowl |
| 07/06/2011 | CN102114128A Traditional Chinese medicine composition for preventing and treating pig high fever |
| 07/06/2011 | CN102114125A Traditional Chinese medicine composition for treating trachoma |
| 07/06/2011 | CN102114123A Traditional Chinese medicine composition for treating avian nephropathogenic infectious bronchitis and preparation method thereof |
| 07/06/2011 | CN102114118A Traditional Chinese medicine composition for preventing and treating porcine circovirus disease |